← Open Payments lookup

EILEEN CHEEVER: Open Payments

NPI 1205099785 · LEOMINSTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$147,614 in 325 payments from 14 companies in 2025. Trend: 2023 $71,645 · 2024 $110,059 · 2025 $147,614

Speaker / faculty: $100,571Travel & lodging: $16,400Consulting: $16,236Honoraria: $9,240Food & beverage: $5,163Education: $5
CompanyPaymentsAmount
Lilly USA, LLC88$44,101
Regeneron Healthcare Solutions, Inc.103$31,141
GENZYME CORPORATION26$17,976
Janssen Biotech, Inc.24$15,399
ABBVIE INC.29$13,124
Organon LLC17$10,403
E.R. Squibb & Sons, L.L.C.14$6,643
Arcutis Biotherapeutics, Inc.3$4,698
Eli Lilly and Company10$3,768
Novartis Pharmaceuticals Corporation1$125

Products named: DUPIXENT, EBGLYSS, TREMFYA, SKYRIZI, VTAMA, Sotyktu, Zoryve, RINVOQ.

Industry payments across MA — which companies pay providers there.